RxDoctor Payments Data

Rindo Sironi, MD

Obstetrics & Gynecology · Billings, MTNPI 1568558500

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (56.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 79.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $3,310, more than ten times the $324 reported in 2019.

$5,331in general payments, 2019–2025

Across 64 payments — averaging $83.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$4K
  • AbbVie$628
  • Astellas Pharma US Inc$100
  • Organon$82
  • Coloplast$79
  • Merck$52
  • plus $178 from 6 others

What the payments were for

  • Travel & lodging$1,07120%
  • Food & beverage$1,25924%
  • Education$3,00056%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,331 in reported general payments places this provider in the 85th percentile of 95 obstetrics & gynecology providers in Montana.

See all obstetrics & gynecology providers in Montana

Medicare billing

Part B allowed, 2024
$39,429
Medicare patients
68
Services billed
1,661

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron18$7,915
Estradiol35$3,978
Solifenacin Succinate42$916
Methenamine Hippurate17$743
Estradiol (Twice Weekly)Estradiol13$611
Norethindrone Acetate13$372
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst12$208

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$100$7,91518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 95 obstetrics & gynecology providers in Montana.

Other obstetrics & gynecology in Billings

See the full list for Montana

Where these figures come from

Is this you, or does something look wrong? →